|
|||||
|
|
Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia |
|
| Authors: | H Al‐Samkari A Kritharis J M Rodriguez‐Lopez D J Kuter |
| Abstract: | |
| Keywords: | hereditary haemorrhagic telangiectasia Osler‐Weber‐Rendu HHT bevacizumab bleeding epistaxis |